Completed Administration of an Orphan Drug ‘Vascostem’ for Treatment of Parry-Romberg Disease by Biostar Stem Cell Research Centre
The Biostar Stem Cell Research Centre (CEO: Ra Jeong Chan) run by Nature Cell and R-Bio announced that it has completed a registration process for an orphan drug in developmental phase for Parry-Romberg Disease, by receiving an official recommendation by The Korean Society of Plastic and Reconstructive Surgeons.
Read more
Most Commented